• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • Webinars
  • Cisema Participates in Canada’s Regulatory Medtech Conference 2021

Cisema Participates in Canada’s Regulatory Medtech Conference 2021

Friday, 28 May 2021 / Published in Webinars

Cisema Participates in Canada’s Regulatory Medtech Conference 2021

Cisema will be participating in Medtech Canada’s Virtual Regulatory Medtech Conference 2021 that will take place on June 2 & 9 and October 20 & 21, 2021.

During the On-Demand Session, Cisema‘s regulatory experts will present the regulatory framework in China for digital health products. The regulation is rapidly evolving as it tracks the fast-moving techhnology changes. Key digital health trends will be discussed including telehealth, internet hospitals and AI/ML products. How does risk class classification for the NMPA (former CFDA) work? Are there any fast-track regulatory pathways? What are the latest updates regarding digital health regulations?

Upon registration of the event, the recorded version of our webinar session will be available for registrants to watch at anytime.  Also, our regulatory experts will answer your questions and better equip you to access China’s digital health market.

Canada’s Regulatory Medtech Conference 2021 – Preliminary Virtual Conference Agenda

Dates: June 2 & 9, 2021 and October 20 & 21, 2021

On-Demand Session Speakers:

Mr. Hamish King, Chief Operating Officer, Cisema (Hong Kong) Limited

Hamish King is a lawyer by training – admitted in Hong Kong and NSW, Australia – supporting companies with difficult regulatory affairs queries for China. Formerly with UK Magic Circle Firm Linklaters in Hong Kong, he has nearly 10 years’ experience in the legal and regulatory fields and has obtained the RAC and CFA qualifications. Regularly writing articles and speaking on China market access and regulatory pathways, he currently lives in Hong Kong and specializes in NMPA registration of medical devices. Hamish has a close interest in the regulatory implications of digital healthcare and AI applications.

Mr. Jacky Li, Sales and Marketing Manager, Cisema (Hong Kong) Limited 

Jacky Li focuses on market updates of medical devices in China (including Hong Kong and the Greater Bay Area) and is the Cisema lead to support the Hong Kong and China regulatory affairs for Taiwan and Hong Kong customers.

Mr. Arthur Ng, North America Business Development Manager, Cisema (Hong Kong) Limited

Arthur Ng attended SUNY in the United States and worked for various companies for 30 years ensuring CPSC, OSHA, and ANSI requirements were met and UL, TUV, IEC and CE regulatory guidelines were strictly adhered to. Arthur currently assists medical devices in Canada and the US with a smooth and efficient registration process in China.

Contact Cisema if you would like to learn more.

What you can read next

Cisema Webinar on the Market Access of Cosmetic Products to China
Cisema Webinar – Cosmetic Registration Under China’s New Regulatory Framework
Quality assurance in purchasing China products
IHK for Bavaria & Cisema Webinar: Online Procurement in China – Quality assurance in purchasing

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP